Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02674997 · ClinicalTrials.gov registry record
GAS-Hem Feasibility Study
A clinical trial, sponsored by Baxalta now part of Shire.
- Completed
- Registry status
- 44
- Enrollment target
NCT02674997 is a clinical trial that has completed, run by Baxalta now part of Shire. The registered enrollment target is 44 participants.
The verdict
NCT02674997 has completed, sponsored by Baxalta now part of Shire.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the feasibility and acceptability of the Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem) as a patient reported outcome (PRO) measure to monitor clinical progress in participant-identified goal areas in individuals with hemophilia A.
Interventions
- BIOLOGICAL Factor VIII
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-08-05 |
| Est. Completion | 2016-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02674997
The ClinicalTrials.gov registry entry for NCT02674997 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxalta now part of Shire, which has 74 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Factor VIII is the first listed.
NCT02674997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02674997 about?
NCT02674997 is a clinical study titled "GAS-Hem Feasibility Study". The purpose of this study is to investigate the feasibility and acceptability of the Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem) as a patient reported outcome (PRO) measure to monitor clinical progress in participant-identified goal areas in individuals with hemophilia A.
What is the current status of trial NCT02674997?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2016-08-05. Estimated completion is 2016-11-02.
What interventions are being tested in trial NCT02674997?
The interventions under investigation include: Factor VIII (BIOLOGICAL).
Who is sponsoring clinical trial NCT02674997?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.